摘要:
The present invention relates to compositions to modulate alpha-secretase and/or to improve cognitive ability. The invention further relates the improved/enhanced cognitive ability in diseased individuals, particularly Alzheimer's Disease patients, and treatment thereof through increased sAPP production. In the present invention PKC activators such as compounds of bryostatin or neristatin class are used for enhancing the cognitive ability.
摘要:
The present invention relates to compositions to modulate alpha-secretase and/or to improve cognitive ability. The invention further relates the improved/enhanced cognitive ability in diseased individuals, particularly Alzheimer's Disease patients, and treatment thereof through increased sAPP production. In the present invention PKC activators such as compounds of bryostatin or neristatin class are used for enhancing the cognitive ability.
摘要:
The present invention relates to compositions to modulate alpha-secretase and/or to improve cognitive ability. The invention further relates the improved/enhanced cognitive ability in diseased individuals, particularly Alzheimer's Disease patients, and treatment thereof through increased sAPP production. In the present invention PKC activators such as compounds of bryostatin or neristatin class are used for enhancing the cognitive ability.